Crispact® Capsules

Product Description

Crispact® is a probiotic food supplement specifically developed to support a healthy vaginal microbiota and promote the dominance of Lactobacillus crispatus, one of the most protective Lactobacillus species in the vaginal environment.

It contains Lactobacillus crispatus M247, a highly characterized strain with excellent vaginal colonization capacity. M247 produces lactic acid, hydrogen peroxide and a class I bacteriocin with antibacterial activity, and remains viable in the presence of boric acid and metronidazole.

Clinical studies in HPV-positive women showed increased HPV clearance and resolution of cervical abnormalities. In women undergoing Assisted Reproductive Technology (ART), Crispact® was associated with increased clinical pregnancy and live birth rates.

PHARMEXTRACTA S.P.A.

Country/Region:

Italy
On CPHI since:

2020
Employees:

100 - 249

Company types

Distributor/Import Export

Wholesale/Retail

Compare Add to favorites Added to favorites

Specifications

Details

Specifications & application areas Probiotic food supplement containing Lactobacillus crispatus M247, a highly characterized strain with strong vaginal tropism and colonization capacity. Designed to support the balance of the vaginal microbiota. Clinically investigated in HPV-positive women and women undergoing Assisted Reproductive Technology (ART).
Selling Points
Product Features; Product Performance; Highly characterized Lactobacillus crispatus M247 with strong vaginal tropism and colonization capacity. M247 produces lactic acid, hydrogen peroxide and a class I bacteriocin with antibacterial activity. Clinically investigated in HPV-positive women and in women undergoing ART, with documented benefits on HPV clearance, cervical abnormalities, clinical pregnancy and live birth rates.
Model

Capsules
Supplied from

Italy
Measured In
piece